Skip to main content
. 2016 May 3;60:10.3402/fnr.v60.31137. doi: 10.3402/fnr.v60.31137

Fig. 2.

Fig. 2

Comparison of different dose COSI, COSIII, and CTS (HFD only, HFD supplemented with low (250 mg/kg·d), middle (500 mg/kg·d), and high (1,000 mg/kg·d) dose COSI, COSIII, and CTS, respectively) in food intake (a), body weight gain (b), fat/body ratio (c), liver (d), and cardiac (e) indices in hyperlipidemic rats during the treatment.